Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Antoni Azón Masoliver

Showing results (1-10 of 8) with videos related to

Pageof 1
Sort By:
Medicina Clinica|March 10, 2015
[Interstitial lung disease induced by hydroxychloroquine]Raquel Català Pérez, Antoni Azón Masoliver, Salvador Hernández Flix
Dermatology Practical & Conceptual|May 26, 2026
Ibrutinib-Related Stellar Hematomas of the PalmsPablo López Sanz, Cristina Grau Salvat, Inmaculada Gil Faure, et al.
Journal Der Deutschen Dermatologischen Gesellschaft = Journal of the German Society of Dermatology : JDDG|April 8, 2017
Lymphoproliferative CD30-positive disorder in a patient with a folliculotropic mycosis fungoidesAriadna Ortiz-Brugués, Rosa-Maria Martí-Laborda, Antoni Azón-Masoliver, et al.
Journal Der Deutschen Dermatologischen Gesellschaft = Journal of the German Society of Dermatology : JDDG|May 10, 2017
CD30-positive lymphoproliferative Erkrankung bei einem Patienten mit follikulotroper Mycosis fungoidesAriadna Ortiz-Brugués, Rosa-Maria Martí-Laborda, Antoni Azón-Masoliver, et al.
Clinical and Experimental Dermatology|March 15, 2026
Intralesional methotrexate for crateriform and non-crateriform keratinocytic tumors: a retrospective case series of 33 patientsPablo López Sanz, Eduardo Escario Travesedo, Joan Àngel Baldó, et al.
Melanoma Research|September 11, 2023
Melanoma-specific survival is worse in the elderly: a multicentric cohort studySonia Segura, Sebastian Podlipnik, Aram Boada, et al.
Clinical and Experimental Dermatology|August 2, 2024
Dupilumab treatment in paediatric atopic dermatitis (2-18 years): Spanish multicentre retrospective real-world studyHelena Iznardo, Esther Roé, Asunción Vicente, et al.
International Journal of Dermatology|September 11, 2025
Tildrakizumab in Psoriatic Patients With Current or Past Malignancy: A Real-Life Cohort and Literature ReviewOfelia Baniandrés, Inmaculada Balaguer Franch, Eva Vilarrasa Rull, et al.
Pageof 1

Showing results (1-10 of 8) with videos related to

Sort By:
Pageof 1
Medicina Clinica|March 10, 2015
[Interstitial lung disease induced by hydroxychloroquine]Raquel Català Pérez, Antoni Azón Masoliver, Salvador Hernández Flix
Dermatology Practical & Conceptual|May 26, 2026
Ibrutinib-Related Stellar Hematomas of the PalmsPablo López Sanz, Cristina Grau Salvat, Inmaculada Gil Faure, et al.
Journal Der Deutschen Dermatologischen Gesellschaft = Journal of the German Society of Dermatology : JDDG|April 8, 2017
Lymphoproliferative CD30-positive disorder in a patient with a folliculotropic mycosis fungoidesAriadna Ortiz-Brugués, Rosa-Maria Martí-Laborda, Antoni Azón-Masoliver, et al.
Journal Der Deutschen Dermatologischen Gesellschaft = Journal of the German Society of Dermatology : JDDG|May 10, 2017
CD30-positive lymphoproliferative Erkrankung bei einem Patienten mit follikulotroper Mycosis fungoidesAriadna Ortiz-Brugués, Rosa-Maria Martí-Laborda, Antoni Azón-Masoliver, et al.
Clinical and Experimental Dermatology|March 15, 2026
Intralesional methotrexate for crateriform and non-crateriform keratinocytic tumors: a retrospective case series of 33 patientsPablo López Sanz, Eduardo Escario Travesedo, Joan Àngel Baldó, et al.
Melanoma Research|September 11, 2023
Melanoma-specific survival is worse in the elderly: a multicentric cohort studySonia Segura, Sebastian Podlipnik, Aram Boada, et al.
Clinical and Experimental Dermatology|August 2, 2024
Dupilumab treatment in paediatric atopic dermatitis (2-18 years): Spanish multicentre retrospective real-world studyHelena Iznardo, Esther Roé, Asunción Vicente, et al.
International Journal of Dermatology|September 11, 2025
Tildrakizumab in Psoriatic Patients With Current or Past Malignancy: A Real-Life Cohort and Literature ReviewOfelia Baniandrés, Inmaculada Balaguer Franch, Eva Vilarrasa Rull, et al.
Pageof 1